You have no items in your shopping cart.
Description
Research Area
Images & Validation
−| Application Notes |
|---|
Key Properties
−| Expression System | HEK293 cell |
|---|---|
| Target | Leukemia inhibitory factor |
| Tag | Tag free |
| Endotoxins | < 1.0 EU/μg as determined by LAL |
| MW | Due to glycosylation, the protein migrates to 40-55 kDa based on Tris-Bis PAGE result. kDa |
| Purity | > 95% as determined by Tris-Bis PAGE; > 95% as determined by SEC-HPLC |
| Protein Sequence | 23-202/202 |
Storage & Handling
−| Storage | Stored at -70°C or -20°C. Avoid repeated freeze/thaw cycles. |
|---|---|
| Concentration | > 0.5 mg/ml |
| Expiration Date | 6 months from date of receipt. |
| Disclaimer | For research use only |
Alternative Names
−Similar Products
−Recombinant human LIF R protein, C-hFc (HEK293) [orb1516391]
> 95% as determined by Tris-Bis PAGE; > 95% as determined by SEC-HPLC
Due to glycosylation, the protein migrates to 120-140 kDa based on Tris-Bis PAGE result. kDa
50 μggp130/IL6ST Protein, Human, Recombinant (His) [orb1960481]
98.00%
68.94 kDa (predicted). Due to glycosylation, the protein migrates to 80-110 kDa based on Tris-Bis PAGE result.
500 μg, 100 μg, 1 mgLIF Protein, Human, Recombinant [orb1955622]
SDS-PAGE: 99.5%; SEC-HPLC: 98.8%
19.7 kDa (predicted); 23-43 kDa (reducing condition, due to glycosylation)
20 μg, 100 μgLIF Protein, Human, Recombinant (His) [orb1956179]
97.90%
21.2 kDa (predicted); 35-42 kDa (reducing conditions)
100 μg, 200 μg, 500 μgLIF Protein, Human, Recombinant (hFc) [orb1956156]
98.00%
46.7 kDa (predicted); 63 kDa (reducing conditions)
100 μg

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].





